American Association for Cancer Research (AACR) Annual Meeting

Sunday, April 2, 2017

Walter E. Washington Convention Center
Washington, DC 

Session DDT01 - New Drugs on the Horizon 1
East Salon A-B, Level 1, Washington Convention Center

Time:  2:30 – 3:00 p.m.

Title:  Durable efficacy and anticancer immunity following intratumoral administration of a combination of messenger RNAs encoding the costimulatory molecule OX40L and the cytokines IL-36g and IL-23

Speaker:  Josh Frederick, Ph.D.
Head of Onkaido Research
Onkaido, a Moderna Venture

Link to Event